Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2744|54|12|1584-1595

ISSN: 0899-1987

Source: Molecular Carcinogenesis, Vol.54, Iss.12, 2015-12, pp. : 1584-1595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content